The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Abstract
BACKGROUND: The pathogenesis of new onset diabetes after transplantation (NODAT) is multifactorial. Suppression of regulatory T lymphocytes may have a negative impact on pancreatic beta-cells. Induction with basiliximab affects regulatory T-cell function and may therefore, theoretically, also affect glucose homeostasis in renal transplant recipients. METHODS: All kidney recipients > or =50 years of age without diabetes mellitus transplanted from 1 January 2005 to 31 December 2007 were included in a single-centre retrospective study. Immunosuppression consisted of steroids, mycophenolate mofetil and cyclosporine. Basiliximab was introduced as induction therapy 1 January 2007. An oral glucose tolerance test (OGTT) was performed in all patients 10 weeks post-transplant. RESULTS: A total of 264 patients were recruited. One hundred and thirty-four patients received basiliximab. In the basiliximab group, 51.5% developed NODAT, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) versus 36.9% in the group without induction therapy (P = 0.017). In recipients with normal OGTT, the mean fasting glucose at 10 weeks was 5.18 mmol/l (SD: 0.54) in the basiliximab group (n = 65) and 4.84 mmol/l (SD: 0.64) in the no induction group (n = 82) (P = 0.001). CONCLUSION: Use of basiliximab as induction therapy may be associated with impaired glucose homeostasis after kidney transplantation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Testosterone may impair gonadotropin secretion and result in impaired spermatogenesis.1570”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1570]
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diabetes Mellitus after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D., & Matas, A. J. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00010.x · Cited by 1,285
Setoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,235
Heisel, O., Heisel, R., Balshaw, R., & Keown, P. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00372.x · Cited by 506 · cited 8×
“Younger recipients were excluded because the immunosuppressive regimen for this age group changed CNI from cyclosporine (CsA) to tacrolimus (Tac) in January 2007.”
BackgroundResultInfluentialCosio, F. G., Pesavento, T. E., Osei, K., Henry, M. L., & Ferguson, R. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002732.x · Cited by 381
Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
Johnston, O., Rose, C. L., Webster, A. C., & Gill, J. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111202 · Cited by 359
Hjelmesæth, J., Hartmann, A., Leivestad, T., Holdaas, H., Sagedal, S., Olstad, M., & Jenssen, T. (2006) · Kidney International · doi:10.1038/sj.ki.5000116 · Cited by 345
Self-citationGLUCOSE INTOLERANCE AFTER RENAL TRANSPLANTATION DEPENDS UPON PREDNISOLONE DOSE AND RECIPIENT AGE1
Hjelmes??th, J., Hartmann, A., Kofstad, J., Stenstr??m, J., Leivestad, T., Egeland, T., & Fauchald, P. (1997) · Transplantation · doi:10.1097/00007890-199710150-00008 · Cited by 309
Self-citationBluestone, J. A., Liu, W., Yabu, J. M., Laszik, Z. G., Putnam, A., Belingheri, M., Gross, D. M., Townsend, R. M., & Vincenti, F. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02377.x · Cited by 233
Hjelmes�th, J., Sagedal, S., Hartmann, A., Rollag, H., Egeland, T., Hagen, M., Nordal, K. P., & Jenssen, T. (2004) · Diabetologia · doi:10.1007/s00125-004-1499-z · Cited by 228
Self-citation
Research works printed but not linked: 1
- 2008, Transplant international : official journal of the European Society for Organ Transplantation, 6, 523
Cited by
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532
“017) at 10 weeks posttransplantation (45).”
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- Aasebo, W., Midtvedt, K., Valderhaug, T. G., Leivestad, T., Hartmann, A., Reisaeter, A. V., Jenssen, T., & Holdaas, H.
- Affiliations
- Oslo University Hospital (NO)
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-23
- Volume
- 25
- Issue
- 4
- Pages
- 1289-1293
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2115385656
- Cited by
- 38
- References
- 22
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 6 · 2014: 6 · 2013: 1 · 2012: 3
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- basiliximab, kidney transplantation, post-transplant diabetes mellitus, impaired glucose tolerance, impaired fasting glucose, glucose homeostasis, induction therapy, regulatory T cells, immunosuppression, oral glucose tolerance test
- MeSH terms
- Basiliximab, Antibodies, Monoclonal, Blood Glucose, Female, Glucose, Glucose Tolerance Test, Graft Survival, Homeostasis, Humans, Immunosuppressive Agents, Male, Middle Aged, Recombinant Fusion Proteins, Retrospective Studies, Kidney Transplantation, Treatment Outcome, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired glucose homeostasis in renal transplant recipients receiving basiliximab. https://app.cochat.ai/papers/10.1093/ndt/gfp617
- The paper
- Aasebo, W., Midtvedt, K., Valderhaug, T. G., Leivestad, T., Hartmann, A., Reisaeter, A. V., Jenssen, T., & Holdaas, H. (2010). Impaired glucose homeostasis in renal transplant recipients receiving basiliximab. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfp617
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.